Biotech stocks can be incredibly attractive for risk-taking investors because of their ability to go parabolic in an instant.

Danish biotech Gubra A/S said its experimental obesity drug showed weight loss and mild side effects in a small study, ...

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when ...

Think of biotech and the bioeconomy as a broad methodology encompassing all those who use and borrow from biology to produce ...

Hera Biotech is developing a less invasive, more accurate diagnostic test for endometriosis, an often painful condition that ...

Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...

Entero has signed a binding term sheet in which private biotech Journey is slated to acquire 99% of Entero’s equity, ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

This month IssueVoter and BillTrack50 take a look at the BIOSECURE Act, a significant escalation in efforts to restrict ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Pipeline and key clinical candidates for these companies: ...

The IPO of Onyx Biotec Limited was fully subscribed for within hours of its Wednesday, November 13 launch. There was a high ...

The existing Goodwill building purchased by Washington University in 2019 and a planned expansion, right, are shown in this ...